Dr. Karl Matussek is Head of Oncology in Germany at AstraZeneca, having joined the company in 2014. He is a trained and PhD graduated biologist. He has spent 17 years with Roche Pharma in Germany in various functions in oncology and hematology.
Matussek is a member of German Association of Hematology and medical Oncology (DGHO), German Cancer Association (DKG) and Working Group Medical Oncology (AIO).
Updated: June 2021